New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
Hologic's Global Women's Health Index reveals concerning trends in women's health worldwide. For the first time, cancer testing among women has declined to just 10%, dropping two percentage points from previous years. The report, based on interviews with over 146,000 people across 142 countries, shows that 38% of women faced food insecurity, while 32% struggled with shelter costs.
The global women's health score remains stagnant at 53 out of 100. Taiwan leads with 68, followed by Kuwait (67), Austria (66), and Switzerland (65). The US scored 60, ranking 37th globally. Key findings include increased rates of worry (42%) and sadness (30%) among women, with 35% feeling unsafe in their communities. The study also revealed low HIV testing rates globally at 6%, with some Middle Eastern and North African countries showing rates below 0.5%.
L'indice globale della salute femminile di Hologic rivela tendenze preoccupanti nella salute delle donne in tutto il mondo. Per la prima volta, i test per il cancro tra le donne sono diminuiti a solo 10%, scendendo di due punti percentuali rispetto agli anni precedenti. Il rapporto, basato su interviste con oltre 146.000 persone in 142 paesi, mostra che 38% delle donne ha affrontato insicurezze alimentari, mentre 32% ha avuto difficoltà con i costi dell'alloggio.
Il punteggio globale per la salute femminile rimane stagnante a 53 su 100. Taiwan guida con 68, seguito dal Kuwait (67), Austria (66) e Svizzera (65). Gli Stati Uniti hanno ottenuto un punteggio di 60, classificandosi 37esimi a livello globale. I principali risultati indicano tassi aumentati di preoccupazione (42%) e tristezza (30%) tra le donne, con il 35% che si sente insicuro nelle proprie comunità. Lo studio ha anche rivelato tassi bassi di test HIV a livello globale, fissati al 6%, con alcuni paesi del Medio Oriente e del Nord Africa che mostrano tassi inferiori allo 0,5%.
El Índice Global de Salud de la Mujer de Hologic revela tendencias preocupantes en la salud de las mujeres en todo el mundo. Por primera vez, las pruebas de cáncer entre mujeres han disminuido a solo 10%, cayendo dos puntos porcentuales en comparación con años anteriores. El informe, basado en entrevistas con más de 146,000 personas en 142 países, muestra que 38% de las mujeres enfrentaron inseguridad alimentaria, mientras que 32% lucharon con los costos de alojamiento.
El puntaje global de salud de la mujer se mantiene estancado en 53 de 100. Taiwán lidera con 68, seguido por Kuwait (67), Austria (66) y Suiza (65). EE. UU. obtuvo un puntaje de 60, ocupando el puesto 37 a nivel global. Los hallazgos clave incluyen un aumento en las tasas de preocupación (42%) y tristeza (30%) entre las mujeres, con un 35% sintiéndose inseguras en sus comunidades. El estudio también reveló tasas bajas de pruebas de VIH a nivel global del 6%, con algunos países de Oriente Medio y África del Norte mostrando tasas inferiores al 0.5%.
호로직의 글로벌 여성 건강 지수는 전 세계 여성 건강에서 우려스러운 경향을 드러냅니다. 처음으로 여성의 암 검사 비율이 10%로 감소했으며, 이는 이전 년도보다 두 퍼센트 포인트 낮아진 수치입니다. 142개국에서 146,000명 이상의 사람들과의 인터뷰에 기반한 이 보고서는 38%의 여성들이 식량 불안에 직면했고, 32%가 주거비용에 어려움을 겪고 있다고 보여줍니다.
전 세계 여성 건강 점수는 100점 만점에 53점으로 정체 상태입니다. 타이완이 68점으로 선두를 차지하며, 그 뒤를 쿠웨이트(67), 오스트리아(66), 스위스(65)가 잇습니다. 미국은 60점으로 전 세계에서 37위를 기록했습니다. 주요 발견 중에는 여성들 사이에서 걱정(42%)과 슬픔(30%)의 비율이 증가했으며, 35%는 지역 사회에서 안전하다고 느끼지 못한다고 보고했습니다. 이 연구는 또한 전 세계적으로 낮은 HIV 검사 비율을 6%로 밝혀냈으며, 일부 중동 및 북아프리카 국가에서는 0.5% 이하의 비율을 보였습니다.
L'indice mondial de la santé des femmes de Hologic révèle des tendances préoccupantes concernant la santé des femmes à travers le monde. Pour la première fois, les dépistages du cancer chez les femmes ont chuté à seulement 10%, soit une baisse de deux points de pourcentage par rapport aux années précédentes. Le rapport, basé sur des entretiens avec plus de 146 000 personnes dans 142 pays, montre que 38% des femmes ont souffert d'insécurité alimentaire, tandis que 32% ont eu des difficultés à payer leur logement.
Le score mondial de santé des femmes reste stable à 53 sur 100. Taïwan est en tête avec 68, suivi du Koweït (67), de l'Autriche (66) et de la Suisse (65). Les États-Unis obtiennent un score de 60, se classant 37e à l'échelle mondiale. Parmi les principales conclusions, on note une augmentation des taux d'inquiétude (42%) et de tristesse (30%) chez les femmes, avec 35% se sentant en insécurité dans leur communauté. L'étude a également révélé des taux de dépistage du VIH très bas à l'échelle mondiale, à 6%, certains pays du Moyen-Orient et d'Afrique du Nord affichant des taux inférieurs à 0,5%.
Hologics globaler Index für die Gesundheit von Frauen zeigt besorgniserregende Trends in der Gesundheit von Frauen weltweit. Erstmals ist die Krebsuntersuchung bei Frauen auf nur 10% gesunken, was einen Rückgang um zwei Prozentpunkte im Vergleich zu den Vorjahren darstellt. Der Bericht, basierend auf Interviews mit über 146.000 Personen aus 142 Ländern, zeigt, dass 38% der Frauen unter Ernährungsunsicherheit litten, während 32% mit den Kosten für Unterkünfte kämpften.
Der globale Gesundheitsindex für Frauen bleibt mit 53 von 100 Punkten stagnierend. Taiwan führt mit 68 Punkten, gefolgt von Kuwait (67), Österreich (66) und der Schweiz (65). Die USA erreichten 60 Punkte und belegten somit den 37. Platz weltweit. Zu den wichtigsten Erkenntnissen gehören steigende Raten von Sorgen (42%) und Traurigkeit (30%) unter Frauen, wobei 35% sich in ihren Gemeinschaften unsicher fühlen. Die Studie ergab auch niedrige HIV-Testquoten von nur 6% weltweit, wobei einige Länder im Nahen Osten und Nordafrika Quoten von unter 0,5% aufweisen.
- 28 countries showed meaningful improvements in their Index scores
- Study covers 97% of world's women and girls aged 15 and older, providing comprehensive data
- Cancer testing among women declined to 10%, down 2 percentage points
- Record-high food insecurity affecting 38% of women
- Increased negative emotional well-being with 42% reporting worry and 30% reporting sadness
- Alarmingly low HIV testing rates globally at 6%
- US ranking dropped 7 places to 37th position
Insights
The decline in cancer testing revealed by Hologic's Global Women's Health Index represents a concerning trend with potential negative implications for HOLX's diagnostic business segment. The 2% drop in cancer testing rates to just 10% globally signals weakening demand for diagnostic services, which could impact Hologic's revenue streams from their cancer screening technologies and diagnostic solutions.
The report's findings about increased financial hardship, with 38% of women unable to afford food, suggest reduced healthcare spending capacity in key markets. This economic pressure could further constrain demand for preventive health services and medical diagnostics, potentially affecting Hologic's market penetration and growth prospects.
For investors, these trends raise concerns about Hologic's near-term revenue outlook in their diagnostic segment. However, the data also highlights a significant untapped market opportunity, as the low testing rates indicate substantial room for growth if access and affordability barriers can be addressed through innovative business strategies and partnerships.
The comprehensive dataset from 142 countries reveals systemic barriers to women's healthcare access that require urgent policy intervention. The alarmingly low 6% HIV testing rate and declining cancer screening trends point to significant gaps in preventive care infrastructure globally.
For Hologic's business model, this presents both challenges and opportunities. The company's position as a leading women's health innovator could be leveraged to develop more accessible and cost-effective diagnostic solutions. The disparities in testing rates between regions also highlight potential growth markets, particularly in the Middle East and North Africa where HIV testing rates are below 0.5%.
The geographic performance variations, with countries like Kazakhstan and Kenya showing improvements, suggest that targeted market entry strategies aligned with local healthcare initiatives could yield positive results. Taiwan's consistent leadership position with a score of 68 provides a benchmark for successful healthcare system integration that could inform Hologic's market development strategies.
Hologic, Inc. (Nasdaq: HOLX), a leading women’s health innovator, partners with Gallup to create the Index. Now in its fourth year, the Index raises new concerns about declining trends in women’s health. For the first time in the history of the Index, women’s cancer testing declined: Only
This year’s Index will be released today during an event convened by Goals House, a community focused on driving progress toward the United Nations (UN) Sustainable Development Goals (SDGs) alongside the World Economic Forum in
“Today’s data reveal a worsening trend in women’s health,” said Stephen P. MacMillan, Chairman, President and CEO of Hologic. “The shocking decline in cancer testing is a wake-up call. Business as usual is not working. Innovative strategies and collaborative efforts are needed to make sustained improvements in women’s health and well-being around the world.”
Key findings from this year’s Index:
-
Cancer Screening Among Women Declined: Only
10% of women said they underwent any type of cancer testing in the past year, reflecting a decrease of two percentage points from the first two years of the survey. -
Women Are Struggling More to Meet Basic Needs: A staggering
38% of women reported being unable to afford food at some point in the past year, marking the highest level of food insecurity in nearly two decades. And32% of women said they could not afford adequate shelter. -
More Women Are Worried and Sad: More women reported feeling worried (
42% ) and sad (30% ) compared to Year 1 of the Index. And over one third (35% ) said they felt unsafe in their communities. -
Ongoing Physical Pain and Health Issues:
34% of women reported experiencing significant pain the previous day, while26% indicated that health problems impacted their ability to engage in everyday activities. -
HIV Testing Rates for Women Are Alarmingly Low: The Index assessed women’s HIV testing for the first time and found concerning disparities: Less than
0.5% of women were tested in certain countries, primarily those in theMiddle East andNorth Africa , and no country scored above41% . Globally, the percentage is much lower. Just6% of women — regardless of whether they visited a healthcare professional or were tested for STIs — said they were tested for HIV in the past year. -
Signs of Hope — Some Countries Are Making Progress: 28 countries saw meaningful increases in their Index scores since the first year of the Index, including
Kazakhstan ,Kenya ,Poland andVenezuela .
The Index assigns a women’s health score to each country or territory based on survey responses on five dimensions of health. Overall, the world scored 53 out of 100 on the Index in Year 4, reflecting no significant change since the Index started.
The Index fills a critical gap in knowledge about the health, safety and well-being of women worldwide. Based on interviews with more than 146,000 women and men in 142 countries and territories, it represents the voices of
To see the full Index and related resources, visit WomensHealthIndex.com.
About Hologic, Inc.
Hologic, Inc. is a global leader in women’s health, dedicated to developing innovative medical technologies that effectively detect, diagnose and treat health conditions and raise the standard of care around the world. For more information on Hologic, visit www.hologic.com and connect with us on LinkedIn, Facebook, X, Instagram and YouTube.
Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in
About Gallup
Gallup delivers analytics and advice to help leaders and organizations solve their most pressing problems. Combining more than 80 years of experience with its global reach, Gallup knows more about the attitudes and behaviors of employees, customers, students and citizens than any other organization in the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250121461870/en/
Investor Contact
Michael Watts
Corporate Vice President, Investor Relations
(+1) 858.410.8514
michael.watts@hologic.com
Media Contact
Bridget Perry
Senior Director, Corporate Communications
(+1) 508.263.8654
bridget.perry@hologic.com
Source: Hologic, Inc.
FAQ
What is the latest cancer testing rate for women according to Hologic's (HOLX) Global Women's Health Index?
How did different countries rank in Hologic's (HOLX) 2024 Global Women's Health Index?
What is the current global HIV testing rate for women according to Hologic's (HOLX) Index?
How did the United States perform in Hologic's (HOLX) latest Women's Health Index?
What percentage of women reported food insecurity in Hologic's (HOLX) latest Index?
